Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 5Motor Activity 3Weight Loss 2Urologic Neoplasms 1Urinary Bladder Neoplasms 1Smoking Cessation 1Neoplasms 1Metabolic Syndrome 1Malnutrition 1Lung Neoplasms 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Surveys and Questionnaires 4Radiosurgery 3amminedichloro(2-methylpyridine)platinum(II) 2Nivolumab 2trastuzumab deruxtecan 1pembrolizumab 1pazopanib 1osimertinib 1motexafin gadolinium 1durvalumab 1cobimetinib 1cemiplimab 1avelumab 1atezolizumab 1alectinib 1Vitamin D 1Transurethral Resection of Prostate 1Therapeutics 1Specimen Handling 1Remote Patient Monitoring 1Oncolytic Virotherapy 1Observation 1Microscopy, Electron 1Memantine 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Immunotherapy 1Immune Checkpoint Inhibitors 1Drug Therapy 1Diet 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Diet × Genitourinary × Clear all
NCT03410641 2018-01-25

Long-term Cancer Risk in the Randomised Oslo Diet and Antismoking Study

Oslo University Hospital

Completed
1,216 enrolled
GastrointestinalGenitourinaryThoracic

Gastrointestinal Neoplasms, Lung Neoplasms, Neoplasms, Prostatic Neoplasms, Urologic Neoplasms, Weight Loss, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡